Psychotropic Drug Therapies and Clinical Considerations in Modern Practice, Volume II
A special issue of Neurology International (ISSN 2035-8377).
Deadline for manuscript submissions: closed (28 February 2024) | Viewed by 317
Special Issue Editors
Interests: pharmacology; anesthesiology; pain management; pain medicine; opioids
Special Issues, Collections and Topics in MDPI journals
Interests: neuroscience; pharmacology; drug abuse; pain management; opioids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rate of progress in psychotropic drug development has been rapid over the last 15 years. There have also been unprecedented rises in expenditure on prescription medications in general and on psychotropic drugs in particular. Psychotropic drugs play a more central role in therapy. They are also closely watched by health insurers, state budget makers, and ordinary people. Modern psychopharmacology has provided therapeutic advantages that have completely revolutionized modern psychiatry. It has also had a significant effect on nosology and psychological disease theories, on hypotheses for psychiatric study, as well as on the preparation of mental health practitioners and the organization of contemporary mental health services.
Prof. Dr. Alan David Kaye
Dr. Elyse M. Cornett
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- opioids
- antidepressants
- ADHD
- PTSD
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
